
Moberg Pharma Investor Relations Material
Latest events

Q4 2024
Moberg Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Moberg Pharma
Access all reports
Moberg Pharma AB develops, manufactures and markets OTC products in the areas of footcare and oral healthcare. The company own the rights to a patented platform technology, which means that they can tailor each product exactly to the needs of each customer. The products are primarily sold through intermediaries and are developed in close collaboration with leading retailers, who sell them on their home markets. Moberg Pharma AB market some of their products directly under their own brands, or via the company's own sales force on a limited number of selected markets.
Key slides for Moberg Pharma


Q4 2024
Moberg Pharma


Q4 2024
Moberg Pharma
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
MOB
Country
🇸🇪 Sweden